Search papers, labs, and topics across Lattice.
A novel (relatively) low-dimensional model is developed to capture the interaction of 26 common pneumococcal serotypes and finds that switching from PPV23 to PCV20 vaccination in those aged 65 and introducing an additional PCV20 vaccine at age 75 are both cost effective for a sufficiently low vaccine price.
